The Phase II STARLIGHT study (NCT05417126) found that a single intravitreal injection of gene-agnostic MCO-010 in six ...

CytomX's Phase I trial of ADC CX-2051 in colorectal cancer will continue based on a decision made by a safety committee ...

According to the US Centers for Disease Control and Prevention, substance use disorder (SUD) affects approximately one in six ...

Remegen's Telitacicept met its primary endpoints in a Chinese trial, while a US-based Phase III trial in Sjögren's syndrome ...

Schrödinger said it is ending development of the CHC7 inhibitor in blood cancer as both a monotherapy and combination.

Aligos has initiated dosing in the Phase II B-SUPREME trial of its ALG-000184 in people with chronic hepatitis B virus (HBV) ...

Vendanta's CEO also announced the company is cutting 20% of its workforce as a result of the Phase II UC trial failure.

CuraCell Holding’s CTA has received approval from Germany's Paul-Ehrlich-Institut (PEI) to begin a Phase I/IIa trial of CC-38 ...

Marea Therapeutics has enrolled the first subject in the MAR-201 Phase I trial of MAR002, aimed at treating acromegaly.

The device for endotoxic septic shock was first approved in Europe more than 20 years ago, in 1994, by Toray Industries.

Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...

Rates of diagnosis and treatment are low, so there is need for diagnostic tests and biomarkers for classification and ...